Cargando…
High‑flow nasal cannula is not more effective than conventional oxygen therapy for acute exacerbation of COPD with mild hypercapnia: we are not sure
Autores principales: | Avdeev, Sergey N., Yaroshetskiy, Andrey I., Nuralieva, Galia S., Avdeev, Ivan S., Shmidt, Anna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153136/ https://www.ncbi.nlm.nih.gov/pubmed/35641997 http://dx.doi.org/10.1186/s13054-022-04022-z |
Ejemplares similares
-
Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022) -
Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19–associated Acute Hypoxemic Respiratory Failure?
por: Avdeev, Sergey N., et al.
Publicado: (2021) -
High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial
por: Xia, Jingen, et al.
Publicado: (2022) -
Can lung ultrasound predict histologic pattern of lung injury in critically ill patients with COVID‑19?
por: Avdeev, Sergey N., et al.
Publicado: (2021) -
How can we predict the failure of awake proning in acute hypoxemic respiratory failure associated with COVID-19?
por: Avdeev, Sergey N., et al.
Publicado: (2022)